Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device
Go back to Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device| (NASDAQ: COCH) | Delayed: 0.66 -0.03 (4.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.69 | 52 Week High | $ | |||
| Open | $0.69 | 52 Week Low | $ | |||
| Day High | $0.69 | P/E | N/A | |||
| Day Low | $0.66 | EPS | $ | |||
| Volume | 158,921 | |||||
